Surgery in ovarian cancer

European Journal of Gynaecological Oncology

Volumn 22, Issue 2, 2001, Pages 89-95

  Boardman, C H ^a   Webb, M J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Neoadjuvant chemotherapy; Primary cytoreduction; Second look laparotomy; Secondary cytoreduction

Indexed keywords

CANCER PALLIATIVE THERAPY; CANCER SURGERY; FEMALE; HUMAN; OVARY CANCER; RECURRENT CANCER; REVIEW; SECOND LOOK SURGERY;

FEMALE; HUMANS; NEOPLASM RECURRENCE, LOCAL; OVARIAN NEOPLASMS; PALLIATIVE CARE; SECOND-LOOK SURGERY;

EID: 0034800194     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Cytoreductive surgery in ovarian carcinoma: Feasibility and morbidity
2. Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: A prospective study
3. Epithelial ovarian carcinoma: Principles of primary surgery
4. The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma
5. The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: A Gynecologic Oncology Group study
6. National survey of ovarian carcinoma. Part V. The impact of physician's specialty on patients' survival
7. National survey of ovarian carcinoma. I. A patient care evaluation study of the American College of Surgeons
8. Patterns of care for women with ovarian cancer in the United States
9. Cytoreduction in ovarian cancer: Achievability and results
10. The pelvic retroperitoneal approach in the treatment of advanced ovarian carcinoma
11. Primary cytoreductive surgery with rectosigmoid colon resection for patients with advanced epithelial ovarian carcinoma
12. Gastrointestinal surgery in patients with ovarian cancer
13. The role of bowel resection in the primary surgical debulking of carcinoma of the ovary
14. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer
15. Hepatic resection for metachronous metastases from ovarian carcinoma
16. Ultrasonic surgical aspirator in cytoreduction of splenic metastases to avoid splenectomy
17. Splenectomy and surgical cytoreduction for ovarian cancer
18. Systematic pelvic and para-aortic lymphadenectomy during cytoreductive surgery in advanced ovarian cancer: Potential benefit on survival
19. Systematic pelvic and paraaortic lymphadenectomy for advanced ovarian cancer: Prognostic significance of node metastases
20. The role of surgery in the management of ovarian cancer: Primary and interval cytoreductive surgery
21. Aggressive chemosurgical debulking in patients with advanced ovarian cancer
22. Neoadjuvant chemotherapy for advanced ovarian cancer: Long-term survival
23. Neoadjuvant chemotherapy in stage X ovarian carcinoma
24. The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer
25. The role of secondary cytoreductive surgery in epithelial ovarian malignancies
26. Second-look laparotomy in advanced ovarian cancer: A critical assessment of morbidity and impact on survival
27. Evaluation of treatment and survival after positive second-look laparotomy
28. Second-look laparotomy-clinical correlations
29. Ten-year follow-up of ovarian cancer patients after second-look laparotomy with negative findings
30. Recurrent disease after negative second-look laparotomy in stages III and IV ovarian carcinoma
31. Influence of secondary cytoreduction at the time of second-look laparotomy on the survival of patients with epithelial ovarian carcinoma
32. Secondary cytoreductive surgery at second-look laparotomy in advanced ovarian cancer: A Gynecologic Oncology Group study
33. Systematic pelvic and paraaortic lymphadenectomy at second-look laparotomy for ovarian cancer
34. Secondary cytoreductive surgery for ovarian cancer
35. Secondary cytoreduction for ovarian cancer following cisplatin therapy
36. Splenectomy in recurrent epithelial ovarian cancer
37. Secondary cytoreductive surgery in ovarian cancer
38. Secondary cytoreductive surgery for recurrent epithelial ovarian cancer
39. Survival of patients following secondary cytoreductive surgery in ovarian cancer
40. Disease-adapted relapse therapy for ovarian cancer: Results of a prospective study
41. Secondary cytoreductive surgery for recurrent ovarian cancer. A prospective study
42. The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinoma